Comments
Bharat Biotech’s Covid-19 vaccine Covaxin has received nod for carrying out phase-III clinical trials from drugs regulatory authorities, reliable sources said here on Tuesday.
The Subject Expert Committee on Covid-19 at the Central Drugs Standard Control Organisation (CDSCO) met here on Tuesday.
The Hyderabad-based Bharat Biotech worked with the Indian Council of Medical Research to develop Covaxin. Recently, the drug regulators allowed the firm to cut down the number volunteers to be used for the vaccine’s phase-II clinical trials as its immunogenicity results in phase-I trials were found to be very good, according to the sources.
Bharat Biotech, Zydus Cadila and Serum Institute of India are some of the frontrunners in Covid-19 vaccine development in India.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.